NeoGenomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
CEOAnthony P. Zook
CEOAnthony P. Zook
Employees2,200
Employees2,200
HeadquartersFort Myers, Florida
HeadquartersFort Myers, Florida
Founded1998
Founded1998
Employees2,200
Employees2,200
NEO Key Statistics
Market cap1.57B
Market cap1.57B
Price-Earnings ratio-13.63
Price-Earnings ratio-13.63
Dividend yield—
Dividend yield—
Average volume2.17M
Average volume2.17M
High today$12.21
High today$12.21
Low today$11.86
Low today$11.86
Open price$12.03
Open price$12.03
Volume962.12K
Volume962.12K
52 Week high$19.12
52 Week high$19.12
52 Week low$4.72
52 Week low$4.72
Stock Snapshot
The current NeoGenomics(NEO) stock price is $12.10, with a market capitalization of 1.57B. The stock trades at a price-to-earnings (P/E) ratio of -13.63.
On 2025-11-29, NeoGenomics(NEO) stock moved within a range of $11.86 to $12.21. With shares now at $12.10, the stock is trading +2.0% above its intraday low and -0.9% below the session's peak.
Trading volume for NeoGenomics(NEO) stock has reached 962.12K, versus its average volume of 2.17M.
Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $19.12 and a low of $4.72.
Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $19.12 and a low of $4.72.
Analyst ratings
53%
of 15 ratingsBuy
40%
Hold
53.3%
Sell
6.7%
People also own
Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.